XML 175 R82.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 12: Stock Compensation Plans: Schedule of Activity of the 2003 Plan (Tables)
12 Months Ended
Dec. 31, 2014
Tables/Schedules  
Schedule of Activity of the 2003 Plan

 

Activity of the stock option plans is summarized as follows:

 Number of Class A Shares

Weighted Average Exercise Price

 

 Number of Class C Shares

Weighted Average Exercise Price

 Outstanding at December 31, 2011

   1,996,543

$    2.40

      361,028

$    2.38

 Adjustment for the effect of stock dividends

       43,928

       24,515

 Granted

      347,000

                -

 Exercised

  (1,041,276)

      (52,500)

 Cancelled

    (123,134)

                -

Reclass from A to C

    (250,808)

      250,808

 Outstanding at December 31, 2012

      972,253

$    2.07

      583,851

$    2.18

 Adjustment for the effect of stock dividends

       17,962

       24,222

 Granted

       81,960

       50,000

 Exercised

    (485,366)

    (190,602)

 Cancelled

      (76,676)

      (63,814)

 Reclass from A to C

    (105,000)

      105,000

 

 

 Outstanding at December 31, 2013

      405,133

$    2.41

      508,657

$    2.00

 Adjustment for the effect of stock dividends

       24,446

       32,934

 Granted

      173,500

      150,000

 Exercised

      (59,713)

                -

 Cancelled

      (30,571)

                -

 

 

 Outstanding at December 31, 2014

      512,795

$    3.20

      691,591

$    2.54

 Exercisable at end of year

      343,987

$    2.50

      547,216

$    2.00

Available options for future grant

      265,198

                -

Weighted average contractual term of options

outstanding at December 31, 2014

7.70 years

3.42 years

Weighted average contractual term of options

exercisable at December 31, 2014

6.65 years

1.79 years

Aggregated intrinsic value of options outstanding

at December 31, 2014 (1)

$1,042,682

$1,856,886

Aggregated intrinsic value of options exercisable

at December 31, 2014 (1)

$940,079

$1,780,498

(1) The Company used a stock price of $5.22 as of December 31, 2014 to derive intrinsic value.